U-Chart Analysis:Daito Pharmaceutical Co.,Ltd.:4577

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Daito Pharmaceutical Co.,Ltd. Go to web site 4577 Medicals 東証プライム May 1, 2000 2010.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Daito Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Balance Sheet 2025年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2024年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2023年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2022年5月期 Daito Pharmaceutical Co.,Ltd. Balance Sheet 2021年5月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2025 May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021
Cash and Cash Equivalents 2,207 2,727 3,607 4,381 3,373
Other Current AssetsHelp 39,501 38,733 37,056 33,528 29,057
Tangible Fixed AssetsHelp 31,826 31,972 25,837 23,116 21,372
Intangible Fixed AssetHelp 531 490 377 386 333
Investments and OthersHelp 3,939 3,786 3,675 3,528 3,605
Total AssetsHelp 78,004 77,708 70,552 64,939 57,739
Total Current LiabilitiesHelp 17,573 19,294 16,435 15,385 14,102
Total Long-term LiabilitiesHelp 8,428 6,345 3,445 2,247 2,019
Shareholder's EquityHelp 52,003 52,069 50,672 47,307 41,619
Total LiabilitiesHelp 78,004 77,708 70,552 64,939 57,739

Daito Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2025年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2024年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2023年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年5月期 Daito Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年5月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2025 May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021
Amount of Sales 50,643 46,895 45,101 43,464 48,715
Total Sales 50,643 46,895 45,101 43,464 48,715
Cost of SalesHelp 42,005 37,056 34,770 32,005 37,917
Other Costs and RevenueHelp 6,729 6,545 6,732 6,791 6,551
Total CostsHelp 48,734 43,601 41,502 38,796 44,469
Net RevenueHelp 8,638 9,839 10,331 11,459 10,798
Earnings Before TaxHelp 2,958 4,218 5,076 6,720 5,874
Net IncomeHelp 1,909 3,294 3,599 4,668 4,246
Net Income 1,909 3,294 3,599 4,668 4,246

Daito Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2025年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2024年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2023年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年5月期 Daito Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年5月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date May 31, 2025 May 31, 2024 May 31, 2023 May 31, 2022 May 31, 2021
Operating Cash Flow(OFC)Help 5,898 5,183 4,156 4,371 5,183
Investing Cash Flow(ICF)Help -7,365 -5,930 -5,566 -4,400 -6,324
Financing Cash FlowHelp 1,002 -183 616 989 1,425
Exchange Difference of Cash and Cash EquivalentsHelp -54 51 20 48 6
Net Increase and Decrease in Cash and Cash Equivalentsn -519 -879 -774 1,008 289

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Daito Pharmaceutical Co.,Ltd.

Company where related level is highHelp

Kidswell Bio Corporation
DENKA SEIKEN Co.,Ltd.
CellSource Co., Ltd.
Chordia Therapeutics
ASKA Pharmaceutical Holdings Co., Ltd.
SymBio Pharmaceuticals Limited
EIKEN CHEMICAL CO.,LTD.
OncoTherapy Science,Inc.
SANTEN PHARMACEUTICAL CO.,LTD.
Tsubota Laboratory Incorporated